相关实验视频

Updated: May 17, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.3K

抑制ADORA1增强了质瘤的亡,并增加了其对抗PD1疗法的敏感性

Hong-Jiang Li1, Zhi-Yun Yu1, Hua-Ping Gao1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Frontiers in oncology
|May 16, 2025
PubMed
概括

在质瘤中抑制腺A1受体 (ADORA1) 促进癌细胞死亡,并增强抗编程死亡受体1 (PD1) 治疗的有效性. 亚多拉1是质瘤的潜在预后标志物.

关键词:
阿多拉 (Adora) 是一个名字.这就是PD1 PD1.灭症 (apoptosis) 是一种死亡的过程.质瘤 质瘤 是一种基诺基因-1 基诺基因-1 基因-1

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

163
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

13.9K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432